These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 27351521)

  • 41. Psychometric properties of the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance and Sleep-Related Impairment item banks in adolescents.
    van Kooten JAMC; Terwee CB; Luijten MAJ; Steur LMH; Pillen S; Wolters NGJ; Kaspers GJL; van Litsenburg RRL
    J Sleep Res; 2021 Apr; 30(2):e13029. PubMed ID: 32180280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT).
    Kaat AJ; Schalet BD; Rutsohn J; Jensen RE; Cella D
    Cancer; 2018 Jan; 124(1):153-160. PubMed ID: 28885707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility of a patient-controlled cognitive-behavioral intervention for pain, fatigue, and sleep disturbance in cancer.
    Kwekkeboom KL; Abbott-Anderson K; Wanta B
    Oncol Nurs Forum; 2010 May; 37(3):E151-9. PubMed ID: 20439200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of self-report sleep measures for individuals with multiple sclerosis and spinal cord injury.
    Fogelberg DJ; Vitiello MV; Hoffman JM; Bamer AM; Amtmann D
    Arch Phys Med Rehabil; 2015 Mar; 96(3):478-83. PubMed ID: 25450136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing psychometric properties of the PROMIS Sleep Disturbance Scale in older adults in independent-living and continuing care retirement communities.
    Full KM; Malhotra A; Crist K; Moran K; Kerr J
    Sleep Health; 2019 Feb; 5(1):18-22. PubMed ID: 30670160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility and validity of a one-item fatigue screen in a thoracic oncology clinic.
    Temel JS; Pirl WF; Recklitis CJ; Cashavelly B; Lynch TJ
    J Thorac Oncol; 2006 Jun; 1(5):454-9. PubMed ID: 17409899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: Cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy.
    Fishbein AB; Lor J; Penedo FJ; Forrest CB; Griffith JW; Paller AS
    J Am Acad Dermatol; 2023 Feb; 88(2):348-356. PubMed ID: 32504726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychometric Evaluation of the Patient-Reported Outcomes Measurement Information System Fatigue-Short Form Across Diverse Populations.
    Ameringer S; Elswick RK; Menzies V; Robins JL; Starkweather A; Walter J; Gentry AE; Jallo N
    Nurs Res; 2016; 65(4):279-89. PubMed ID: 27362514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PROMIS global health: potential utility as a screener to trigger construct-specific patient-reported outcome measures in clinical care.
    Lapin B; Katzan IL
    Qual Life Res; 2023 Jan; 32(1):105-113. PubMed ID: 35947238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients.
    Cessna JM; Jim HS; Sutton SK; Asvat Y; Small BJ; Salsman JM; Zachariah B; Fishman M; Field T; Fernandez H; Perez L; Jacobsen PB
    J Psychosom Res; 2016 Feb; 81():9-13. PubMed ID: 26800633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure symptom burden reported by patients with brain tumors.
    Lai JS; Kupst MJ; Beaumont JL; Manley PE; Chang JH; Hartsell WF; Kwok Y; Fisher AP; Goldman S
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27526. PubMed ID: 30426667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study.
    Griffiths EA; Min JS; Lee WN; Yu JC; Patel Y; Myren KJ; Dingli D
    Health Qual Life Outcomes; 2024 Aug; 22(1):62. PubMed ID: 39123253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The PROMIS physical function scale: A promising scale for use in patients with ischemic stroke.
    Katzan IL; Fan Y; Uchino K; Griffith SD
    Neurology; 2016 May; 86(19):1801-7. PubMed ID: 27164715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.
    George GC; Iwuanyanwu EC; Anderson KO; Yusuf A; Zinner RG; Piha-Paul SA; Tsimberidou AM; Naing A; Fu S; Janku F; Subbiah V; Cleeland CS; Mendoza TR; Hong DS
    Cancer; 2016 Nov; 122(21):3401-3409. PubMed ID: 27412379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Brazilian validation of the item banks on Sleep Disturbance and Wake Disturbance in the Patient-Reported Outcomes Measurement Information System (PROMIS)].
    Silva e Costa ZMS; Pinto RMC; Mendonça TMDS; Silva CHMD
    Cad Saude Publica; 2020; 36(6):e00228519. PubMed ID: 32520128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes.
    Austad C; Kvien TK; Olsen IC; Uhlig T
    Scand J Rheumatol; 2017 Mar; 46(2):95-103. PubMed ID: 27319613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance of PROMIS for Healthy Patients Undergoing Meniscal Surgery.
    Hancock KJ; Glass N; Anthony CA; Hettrich CM; Albright J; Amendola A; Wolf BR; Bollier M
    J Bone Joint Surg Am; 2017 Jun; 99(11):954-958. PubMed ID: 28590381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study.
    Orbai AM; Coates LC; Deodhar A; Helliwell PS; Ritchlin CT; Leibowitz E; Kollmeier AP; Hsia EC; Xu XL; Sheng S; Jiang Y; Liu Y; Han C
    Patient; 2022 Nov; 15(6):657-668. PubMed ID: 35768650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort.
    Jensen RE; Moinpour CM; Potosky AL; Lobo T; Hahn EA; Hays RD; Cella D; Smith AW; Wu XC; Keegan TH; Paddock LE; Stroup AM; Eton DT
    Cancer; 2017 Jan; 123(2):327-335. PubMed ID: 27696377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility of Patient-Reported Outcomes Measurement Information System (PROMIS®) computerized adaptive tests in systemic lupus erythematosus outpatients.
    Kasturi S; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    Lupus; 2018 Sep; 27(10):1591-1599. PubMed ID: 29793381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.